Coming Soon

Welcome to BioTrends Research Group

Our Mission

BioTrends is the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.

By extension of our syndicated publications, BioTrends partners with clients to provide custom research solutions that allow clients to intimately understand their markets and to make informed business decisions.

Recent News

December 1, 2008
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTrends Report
Read more...Link
November 19, 2008
New Study by BioTrends Highlights Practice Management Shifts Among Canadian Nephrologists
Read more...Link
October 27, 2008
BioTrends Research Group, Inc. Recognized as one of Philadelphia’s Fastest Growing Privately Held Companies
Read more...Link
October 27, 2008
BioTrends Releases TreatmentTrendsTM: Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
Read more...Link
BioTrends Releases 2009 Syndicated Publication Plan
TreatmentTrends™ reports are now offered in 19 unique therapeutic/global markets Read more...Link
September 17, 2008
Use of Biologic Agents Continues To Expand Among US Rheumatologists – Can New Agents Shift the Treatment Paradigm in Rheumatoid Arthritis?
Read more...Link
September 15, 2008
According to Nephrologists, Use of Genzyme’s New Phosphate Binder Renvela® (sevelamer carbonate) has Greatly Increased in the Past Two Months
Read more...Link